Unfolded protein response mediated JNK/AP-1 signal transduction, a target for ovarian cancer treatment

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 6, 2015, Pages 6505-6511

  Zheng, Gao Feng ^a   Cai, Zhen ^a   Meng, Xiang Kai ^b   Zhang, Yi ^b   Zhu, Wei ^b   Pang, Xiao Yan ^b   Dou, Lei ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Diindolylmethane; Endoplasmic reticulum stress; EpCAM; SKOV3 cells

Indexed keywords

ANTINEOPLASTIC AGENT; BCL2 PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASPASE 3; CELL ADHESION MOLECULE; DIINDOLYLMETHANE; EPCAM PROTEIN, HUMAN; EPITHELIAL CELL ADHESION MOLECULE; INDOLE DERIVATIVE; PROTEIN BCL 2; PROTEIN KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR ANTIGEN;

ANTAGONISTS AND INHIBITORS; AUTOPHAGY; DOSE RESPONSE; DRUG EFFECTS; ENDOPLASMIC RETICULUM; ENZYMOLOGY; FEMALE; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; OVARIAN NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE; UNFOLDED PROTEIN RESPONSE;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CASPASE 3; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPLASMIC RETICULUM; EPITHELIAL CELL ADHESION MOLECULE; FEMALE; HUMANS; INDOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR TARGETED THERAPY; OVARIAN NEOPLASMS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; UNFOLDED PROTEIN RESPONSE;

EID: 84938629447     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gorlach A, Klappa P, Kietzmann T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Sign 2006; 8: 1391-1418.
2. Ermak G and Davies KJ. Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 2002; 38: 713-721.
3. Ma Y and Hendershot LM. The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 2004; 4: 966-977.
4. Schroder M and Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 2005; 74: 739-789.
5. Perez-Sala D and Mollinedo F. Inhibition of N-linked glycosylation induces early apoptosis in human promyelocytic HL-60 cells. J Cell Physiol 1995; 163: 523-531.
6. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000; 287: 664-666.
7. Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, Ichijo H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 2002; 16: 1345-1355.
8. Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K, Masutani H, Yodoi J, Urano Y, Nagano T, Ichijo H. Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ 2005; 12: 19-24.
9. Nozaki S, Sledge GW Jr, Nakshatri H. Repression of GADD153/CHOP by NF-kappaB: A possible cellular defense against endoplasmic reticulum stress-induced cell death. Oncogene 2001; 20: 2178-2185.
10. Jochum W, Passegue E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene 2001; 20: 2401-2412.
11. Sankpal NV, Mayfield JD, Willman MW, Fleming TP, Gillanders WE. Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion. Breast Cancer Res 2011; 13: R124.
12. Baeuerle PA and Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007; 96: 417-423.
13. Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, von Castelberg B, Bart R, Stopatschinskaya S, Köchli OR, Haas P, Mross F, Zuber M, Dietrich H, Bischoff S, Mirlacher M, Sauter G, Gastl G. High Ep-CAM expression is associated with poor prognosis in nodepositive breast cancer. Breast Cancer Res Treat 2004; 86: 207-213.
14. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, Dirnhofer S. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004; 35: 122-128.
15. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 2004; 11: 448-457.
16. Rouschop KM, Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW, Lambin P, Kogel AJ, Koritzinsky M, Wouters BG. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest 2010; 120: 127-141.
17. Kandala PK and Srivastava SK. Activation of checkpoint kinase 2 by 3,3'-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells. Mol Pharmacol 2010; 78: 297-309.
18. Denmeade SR and Isaacs JT. The SERCA pump as a therapeutic target: making a "smart bomb" for prostate cancer. Cancer Biol Ther 2005; 4: 14-22.
19. Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010; 40: 280-293.
20. Lizundia R, Sengmanivong L, Guergnon J, Muller T, Schnelle T, Langsley G, Shorte SL. Use of micro-rotation imaging to study JNK-mediated cell survival in Theileria parva-infected B-lymphocytes. Parasitology 2005; 130: 629-635.
21. Lizundia R, Chaussepied M, Huerre M, Werling D, Di Santo JP, Langsley G. c-Jun NH2-terminal kinase/c-Jun signaling promotes survival and metastasis of B lymphocytes transformed by Theileria. Cancer Res 2006; 66: 6105-6110.
22. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 2001; 98: 13681-13686.